BACKGROUND New and more severe clinical manifestations associated with the coronavirus disease 2019(COVID-19) are emerging constantly in the pediatric age group.Patients in this age group are also primary carriers of ...BACKGROUND New and more severe clinical manifestations associated with the coronavirus disease 2019(COVID-19) are emerging constantly in the pediatric age group.Patients in this age group are also primary carriers of the influenza virus and are at a higher risk of developing severe infection.However,studies comparing influenza and COVID-19 to show which condition causes a more severe form of disease amongst the pediatric age group are scarce.AIM To compare the laboratory results,clinical symptoms and clinical outcomes in pediatric patients with COVID-19 and influenza.METHODS A systematic and comprehensive search was carried out in databases and search engines,including EMBASE,Cochrane,MEDLINE,ScienceDirect and Google Scholar from 1964 until January 2022.A meta-analysis was carried out using a random-effects model and pooled odds ratio(OR) or standardized mean difference(SMD) and 95%CI.RESULTS A total of 16 studies satisfied the inclusion criteria.Pediatric COVID-19 patients had a significantly reduced risk of cough(pooled OR = 0.16;95%CI:0.09 to 0.27),fever(pooled OR = 0.23;95%CI:0.12 to 0.43),and dyspnea(pooled OR = 0.54;95%CI:0.33 to 0.88) compared to influenza patients.Furthermore,total hemoglobin levels(pooled SMD = 1.22;95%CI:0.29 to 2.14) in COVID-19 patients were significantly higher as compared to pediatric influenza patients.There was no significant difference in symptoms such as sore throat,white blood cell count,platelets,neutrophil and lymphocytes levels,and outcomes like mortality,intensive care unit admission,mechanical ventilation or length of hospital stay.CONCLUSION COVID-19 is associated with a significantly lower rate of clinical symptoms and abnormal laboratory indexes compared to influenza in the pediatric age group.However,further longitudinal studies of the outcomes between influenza and COVID-19 pediatric patients are needed.展开更多
文摘BACKGROUND New and more severe clinical manifestations associated with the coronavirus disease 2019(COVID-19) are emerging constantly in the pediatric age group.Patients in this age group are also primary carriers of the influenza virus and are at a higher risk of developing severe infection.However,studies comparing influenza and COVID-19 to show which condition causes a more severe form of disease amongst the pediatric age group are scarce.AIM To compare the laboratory results,clinical symptoms and clinical outcomes in pediatric patients with COVID-19 and influenza.METHODS A systematic and comprehensive search was carried out in databases and search engines,including EMBASE,Cochrane,MEDLINE,ScienceDirect and Google Scholar from 1964 until January 2022.A meta-analysis was carried out using a random-effects model and pooled odds ratio(OR) or standardized mean difference(SMD) and 95%CI.RESULTS A total of 16 studies satisfied the inclusion criteria.Pediatric COVID-19 patients had a significantly reduced risk of cough(pooled OR = 0.16;95%CI:0.09 to 0.27),fever(pooled OR = 0.23;95%CI:0.12 to 0.43),and dyspnea(pooled OR = 0.54;95%CI:0.33 to 0.88) compared to influenza patients.Furthermore,total hemoglobin levels(pooled SMD = 1.22;95%CI:0.29 to 2.14) in COVID-19 patients were significantly higher as compared to pediatric influenza patients.There was no significant difference in symptoms such as sore throat,white blood cell count,platelets,neutrophil and lymphocytes levels,and outcomes like mortality,intensive care unit admission,mechanical ventilation or length of hospital stay.CONCLUSION COVID-19 is associated with a significantly lower rate of clinical symptoms and abnormal laboratory indexes compared to influenza in the pediatric age group.However,further longitudinal studies of the outcomes between influenza and COVID-19 pediatric patients are needed.
